These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15916595)

  • 1. Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo.
    Pohlhaus JR; Kreuzer KN
    Mol Microbiol; 2005 Jun; 56(6):1416-29. PubMed ID: 15916595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
    Hong G; Kreuzer KN
    Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.
    Aedo S; Tse-Dinh YC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5458-64. PubMed ID: 22869559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase IV is a target of quinolones in Escherichia coli.
    Khodursky AB; Zechiedrich EL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11801-5. PubMed ID: 8524852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of RuvABC and RecG involvement in the escherichia coli response to the covalent topoisomerase-DNA complex.
    Sutherland JH; Tse-Dinh YC
    J Bacteriol; 2010 Sep; 192(17):4445-51. PubMed ID: 20601468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
    Hsu YH; Chung MW; Li TK
    Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-Gyrase-DNA Cleaved Complexes.
    Luan G; Drlica K
    Methods Mol Biol; 2018; 1703():269-281. PubMed ID: 29177748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin-induced DNA cleavage occurs at the dif resolvase locus in Escherichia coli and is the result of interaction with topoisomerase IV.
    Hojgaard A; Szerlong H; Tabor C; Kuempel P
    Mol Microbiol; 1999 Sep; 33(5):1027-36. PubMed ID: 10476036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex.
    Hiasa H; Yousef DO; Marians KJ
    J Biol Chem; 1996 Oct; 271(42):26424-9. PubMed ID: 8824300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
    Khodursky AB; Cozzarelli NR
    J Biol Chem; 1998 Oct; 273(42):27668-77. PubMed ID: 9765303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
    González-Soltero R; García-Cañas A; Mohedano RB; Mendoza-Chamizo B; Botello E
    Rev Esp Quimioter; 2015 Jun; 28(3):139-44. PubMed ID: 26032998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of quinolones against Escherichia coli DNA gyrase.
    Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.
    Fournier B; Zhao X; Lu T; Drlica K; Hooper DC
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2160-5. PubMed ID: 10898691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex.
    Wentzell LM; Maxwell A
    J Mol Biol; 2000 Dec; 304(5):779-91. PubMed ID: 11124026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes.
    Shen LL; Kohlbrenner WE; Weigl D; Baranowski J
    J Biol Chem; 1989 Feb; 264(5):2973-8. PubMed ID: 2536729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes.
    Shea ME; Hiasa H
    J Biol Chem; 1999 Aug; 274(32):22747-54. PubMed ID: 10428858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action.
    Strumberg D; Nitiss JL; Dong J; Walker J; Nicklaus MC; Kohn KW; Heddle JG; Maxwell A; Seeber S; Pommier Y
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2735-46. PubMed ID: 12183223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of DNA Supercoil Geometry by Mycobacterium tuberculosis Gyrase.
    Ashley RE; Blower TR; Berger JM; Osheroff N
    Biochemistry; 2017 Oct; 56(40):5440-5448. PubMed ID: 28921956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.